The regulatory landscape in the United Arab Emirates is undergoing significant transformation, with the country continuing to strengthen and centralise oversight of healthcare products through the **Emirates Drug Establishment> (EDE). Recent developments in 2026 highlight the UAE’s broader strategy to modernise healthcare regulation, improve efficiency, and position the country as a leading regional hub for healthcare innovation and market access. For medical device and pharm